Top News
Latest News
PARTNERSHIPS
17 Feb 2026
Pfizer Steps Up Obesity Push With Metsera DealINSIGHTS
16 Feb 2026
AI Drugmaker Targets Obesity Beyond GLP-1REGULATORY
12 Feb 2026
FDA Tightens Grip on GLP-1 CopycatsINNOVATION
11 Feb 2026
The New Front Line in AI Drug Discovery
AstraZeneca Bets on AI to Rethink Obesity Care
PARTNERSHIPS
10 Feb 2026
AstraZeneca and CSPC join forces, blending AI and long-acting dosing to speed new obesity and diabetes drugs across global markets
PARTNERSHIPS
26 Jul 2025
One Shot for Cholesterol? Lilly Thinks the Future Is Here
Lilly's Verve buyout could turn lifelong cholesterol drugs into a one-time genetic fix.
INNOVATION
28 Jun 2025
CRISPR’s Bold Bet: One Shot to Disrupt Cholesterol Care
CTX310 shows up to 86% LDL reduction in early trial, with full results expected in 2025
INNOVATION
25 Jun 2025
From Needle to Pill: The New Face of Obesity Treatment
Novo's amycretin pill shows big early weight-loss results, hinting at a future beyond injections.
RESEARCH
21 Jun 2025
Stem Cell Trial Offers Hope for Insulin-Free Diabetes
Vertex's zimislecel left most trial patients insulin-free after a year, but safety risks and scalability remain major hurdles
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.